Urumqi, Xinjiang, China - From September 19 to 23, 2022, the 7^th China-Eurasia Expo (referred to as "the Expo") themed by “Wide Discussion, Joint Contribution and Shared Benefits: Towards the Future of Cooperation” was successfully held at the Xinjiang International Convention and Exhibition Center in Urumqi. Shanghai MicroPort MedBot (Group) Co., Ltd. (referred to as MicroPort^® MedBot^®), a leading surgical robot enterprise in China, presented its flagship products Toumai^® LaparoscopicSurgical Robot, Honghu Orthopedic Surgerical Robot, and DFVision^® 3D Electronic Laparoscope to exhibitors and visitors from four corners of the world, demonstrating the outstanding style and powerful strength of medical robots manufactured by China's intelligence.

The Expo, co-sponsored by the Ministry of Commerce, the Ministry of Foreign Affairs, the CCPIT, the People's Government of Xinjiang Uygur Autonomous Region of China, etc., is an international economic and trade exchange event at the national level. As an important platform for the construction of the core area of The Silk Road, it is an important platform for China to carry out summit diplomacy with neighboring countries, as well as an important channel for Xinjiang to cooperate with its neighboring countries and showcase its good image to the outside. The Expo is set up with three major exhibition areas of investment and cooperation, international section and commodity trade. Exhibition topics include digital and high-tech equipment, cultural tourism and sports industry, energy industry, agricultural products, food, textiles, clothing and books, attracting a wide array of well-known domestic and foreign enterprises from Asia, Europe, America, Africa, Oceania and many other countries (regions) to sign up for attending the Expo on-line or off-line, including dozens of world and China's top 500 enterprises and multinational enterprises. The offline Expo covers an area of 40,000 square meters, and the online Expo has 3,600 enterprise exhibitors from 32 countries (regions) participating with 16,980 exhibits.

In the Expo, MicroPort^® MedBot^® brought a series of cutting-edge medical technology products, including the first domestic four-arm endoscopic surgical robot - Toumai^® Laparoscopic Surgical Robot, Honghu Orthopedic Surgical Robot, the only one approved by the U.S. Food and Drug Administration (FDA) among its similar products, and DFVision^® 3D Electronic Laparoscope entering the "green channel", and all of them has demonstrated latest technological trends in the surgical robot industry as intelligent technologies, minimally invasive treatment and 5G telemedicine.

Among them, Toumai^® is a domestic laparoscopic surgical robot independently researched and developed by MicroPort^® MedBot^® and approved for marketing by the National Medical Products Administration in January 2022, making it the first and only four-arm endoscopic robot independently researched and developed by a Chinese enterprise and approved for marketing so far. Toumai^® Laparoscopic Surgical Robot is a high-end medical device that integrates multidisciplinary high technology, consisting of a surgeon console, a patient cart and a vision cart. It adopts master-slave teleoperation technology to realize the surgical mode of doctors conducting the operation in a seated position away from the surgical console, thus reducing their burdens. Toumai^® boasts clinical advantages such as three-dimensional realistic surgical fields and highly flexible wrist surgical instruments and has showcased its effectiveness and safety in clinical trials, making it widely applicable in all kinds of surgeries, including urologic surgical procedures.

Honghu Orthopedic Surgical Robot, the only one certified by the FDA among its similar products in China, marks that China's surgical robot industry innovation has entered the international advanced ranks. Honghu has demonstrated technical advantages in terms of precision, synergy, safety and compatibility. Before the operation, the system’s planning system can help the surgeon develop a personalized plan for prosthetic implantation based on the patient's CT scan data and prosthetic model data. During operations, it draws on the precise positioning of surgical planning to quickly complete an osteotomy and improve surgical accuracy and efficiency through registration techniques combined with the highly dexterous lightweight robotic arm that is independently researched and developed. With Honghu, medullary cavity positioning and intramedullary rod implantation typically needed in traditional surgery can be avoided, thereby reducing surgical injury and bleeding, improving lower limb strength line postoperatively, reducing complications, and helping patients recover quickly.

Multiple types of domestic surgical robot products brought by the MicroPort^® MedBot^® booth attracted an endless stream of visitors, who carefully observed the demonstrations and learn about the technical advantages. When knowing that Toumai^®, spanning nearly 5000 kilometers from Nanjing, Jiangsu to Kizilsu Kirgiz Autonomous Prefecture, Xinjiang, performed the world’s farthest 5G robotic telesurgery for a number patients in Xinjiang, they felt proud for us that China Intelligent Manufacturing surgical robots should create such a historical record, and placed high hopes for Toumai^® in helping hospitals in remote and underdeveloped areas to carry out difficult and complicated surgeries.

The reason for this record lies in the perfect integration of 5G technology and robotics, as well as the fact that Toumai^® has kept continuously meeting surgery challenges, completed many difficult urological surgeries, and assisted clinical experts in achieving a number of milestone breakthroughs with important clinical value. It includes the first domestic robotic radical prostatectomy, the first domestic robotic partial nephrectomy, and the first domestic robotic partial nephrectomy via retroperitoneal approach. This series of surgical records all signify that the domestic endoscopic surgical robot independently researched and developed by China has the ability to assist doctors in completing complicated surgeries in a narrow anatomical space, filling the gap of domestic intelligent manufacturing in this field.

The most impressive part is that an elderly man in a self-service vehicle couldn’t help but sigh at the rapid changes and great achievements of the surgical robot technology independently researched and developed by Chinese after listening to the staff's on-site introduction, which was deeply impressed and touched. He said that he kept an eye on the dynamics and development of medical care due to his physical problems caused by the lack of sound medical resources and conditions in the past and now he was delighted that MicroPort^® MedBot^® has developed such excellent domestic intelligent manufacturing and full of hope that ordinary patients can enjoy more high-tech and higher quality treatment services in the future.

In addition to experts and people from all walks of life,  MicroPort^® MedBot^® booth also attracted many mainstream media such as Xinhua News Agency, Guangming Daily and Xinjiang Daily, and all were full of admiration for the outstanding achievements of the domestic surgical robot in empowering hospitals via cutting-edge technologies.

China-Eurasia Expo brings MicroPort® MedBot^® to the world to take us to run towards a win-win future. MicroPort^® MedBot^® showed the strong strength of China's domestic surgical robots on a world-class stage at China-Eurasia Expo, gaining attention and favor from all circles. In the future, MicroPort^® MedBot^® will based on experience and achievements made at this Expo, further leverage the effect of the Asia-Europe Expo platform featuring openness and win-win to accelerate the promotion of medical technologies and products in markets below the third-tier cities, provide more learning and experience opportunities for clinicians, and help more ordinary patients access high-end medical resources without leaving the city or county, thus contributing to the construction of "Health China 2030" with richer and more intelligent medical solutions. We will also keep in line with the international advanced medical technology to achieve the belief of “Make surgery easier, safer and less invasive”.

The registered trademark of Honghu is named “SkyWalker” in abroad , which is in the process of application in USA, completed registration in EU and other countries and regions.